Lopes, A.J.O.; Calado, G.P.; Fróes, Y.N.; Araújo, S.A.d.; França, L.M.; Paes, A.M.d.A.; Morais, S.V.d.; Rocha, C.Q.d.; Vasconcelos, C.C.
Plant Metabolites as SARS-CoV-2 Inhibitors Candidates: In Silico and In Vitro Studies. Pharmaceuticals 2022, 15, 1045.
https://doi.org/10.3390/ph15091045
AMA Style
Lopes AJO, Calado GP, Fróes YN, Araújo SAd, França LM, Paes AMdA, Morais SVd, Rocha CQd, Vasconcelos CC.
Plant Metabolites as SARS-CoV-2 Inhibitors Candidates: In Silico and In Vitro Studies. Pharmaceuticals. 2022; 15(9):1045.
https://doi.org/10.3390/ph15091045
Chicago/Turabian Style
Lopes, Alberto Jorge Oliveira, Gustavo Pereira Calado, Yuri Nascimento Fróes, Sandra Alves de Araújo, Lucas Martins França, Antonio Marcus de Andrade Paes, Sebastião Vieira de Morais, Cláudia Quintino da Rocha, and Cleydlenne Costa Vasconcelos.
2022. "Plant Metabolites as SARS-CoV-2 Inhibitors Candidates: In Silico and In Vitro Studies" Pharmaceuticals 15, no. 9: 1045.
https://doi.org/10.3390/ph15091045
APA Style
Lopes, A. J. O., Calado, G. P., Fróes, Y. N., Araújo, S. A. d., França, L. M., Paes, A. M. d. A., Morais, S. V. d., Rocha, C. Q. d., & Vasconcelos, C. C.
(2022). Plant Metabolites as SARS-CoV-2 Inhibitors Candidates: In Silico and In Vitro Studies. Pharmaceuticals, 15(9), 1045.
https://doi.org/10.3390/ph15091045